期刊文献+

慢性髓性白血病细胞染色体检测的临床意义 被引量:2

下载PDF
导出
摘要 目的探讨慢性髓性白血病(CML)染色体变化对CML病情及预后判断的意义。方法用直接法或短期24h培养法常规R显带后分析97例CML患者骨髓单个核细胞核型并统计分析其与患者预后关系。结果97例CML患者中,Ph1染色体(+)者92例(94·8%);Ph1(-)者5例(5·2%),其中有4例Ph1(-)bcr/abl(+),1例Ph1(-)/bcr/abl(-)。加速期、急变期患者17例(17·2%)中有15例出现新的染色体异常,表现为+8、+19、+Ph1、-Y、i(17q)、del(7)(q22)。加速期、急变期患者额外染色体出现频率显著高于慢性期患者。结论CML患者染色体畸变频率增高及非随机同时出现额外染色体提示患者预后不佳。
出处 《临床检验杂志》 CAS CSCD 北大核心 2007年第1期56-57,共2页 Chinese Journal of Clinical Laboratory Science
基金 镇江市社会发展基金(2004-007)。
关键词 CML 染色体 预后
  • 相关文献

参考文献10

  • 1Zitzelsberger H, Bauchinger M, Wilmanns W, et al. Cytogenetic and molecular analysis of a "masked" Philadelphia chromosome in chronic and balstic phases of chronic myeliod leukemia[ J]. Cancer Genet Cytogenet, 1990,47 ( 2 ) :219-225.
  • 2林茂芳,谢万灼,陈志妹,陈巧芳,黄河.236例慢性粒细胞白血病患者细胞遗传学特性观察[J].中华血液学杂志,2000,21(1):36-36. 被引量:14
  • 3刘元波,郝玉书.慢性粒、单核细胞白血病[J].中华血液学杂志,1996,17(5):274-275. 被引量:5
  • 4Honda H, Ushijima T, Wakazono K, et al. Acquired loss of P53 induces blastic transformation in p210-expressing hematopoietic cells:a transgenis study for blast of human CML[ J]. Blood,2000,95:1144.
  • 5Kudam P R, Nanjangud G J, Advani S H,et al. Chromosomal characteritis of chronic meloid leukemia. A study of 100 patients in India[J]. Cancer Genet Cytogenet, 1991,51 (2) : 167-171.
  • 6Xinh P T,Vu H A,Van Man H, et al, Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam [ J ], Camcer Genet Cytogenet, 2006,168( 1 ) :59-68,
  • 7Babicka L, Zemanova Z, Pavlistova L,et al. Complex chromosomal rearrangements in patients with chronic myeloid leukemia [ J ]. Cancer Genet Cytogenet,2006,168 (1) : 22-29.
  • 8Fourouclas N, Campbell P J, Bench A J, et al. Size matters : the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia[J]. Haematologica,2006,1 (7) :952-955.
  • 9Thauta V M. Chronic myelogenous leukemia : elements of conventional chemotherapy and anoverview of autografting in the treatment of the chronic phase[J]. Med oncol,2003,20(2) :95-116.
  • 10Takeuchi J, Miura K,Hatta Y,et al. Durable molecular complete remission induced by low-dose imatinib plus low-dose interferon alpha in a patient with chronic myelogenous leukaemia[J]. J Int Med Res, 2006,34( 1 ) : 103-108.

二级参考文献1

  • 1张之南,血液病诊断及疗效标准,1991年,193页

共引文献17

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部